OUR JOURNEYS

Patient story

Nairivis Maiz Gonzalez

Read the English Version

"Desde ese momento estoy en una constante lucha con esta enfermedad."

Nairivis Maiz GonzalezTengo 32 años nací con una cardiopatia. En el año 1984, cuando solo tenia 4 años desarrolle HP, producto de esta condición congénita. Desde ese momento estoy en una constante lucha con esta enfermedad sin embargo, tengo una vida normal y parezco una persona saludable aunque algunos días sienta los embates de este mal. mi tratamiento no ha sido mas que Nifedipino(antagonista del calcio) desde el momento del diagnostico y hace unos meses tomo sildenafil ademas de diuréticos, anticoagulantes entre otros.

 

English Version

"I have been in a constant battle with this disease."

I am 32 years old and I was born with a heart defect. In 1984, when I was only 4, I developed PH as a product of this congenital condition. Since that moment I have been in a constant battle with this disease; however, I have a normal life and I seem like a healthy person (although some days I feel the effects of the fight). My treatment has been limited to Nifedipina (calcium antagonist) from the diagnosis, and as of a few months ago, sildenafil, diuretics, and anticoagulants, among others.

 

 

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

For the best viewing experience of this site, it is recommended that you use Internet Explorer 8 or 9 or Firefox.

© 2014 Pulmonary Hypertension Association. All Rights Reserved.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Provide Feedback & Report Bugs

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.